Niche Probiotic Focus Bien-Etre Labs specializes in developing and commercializing bioactive probiotic agents aimed at promoting healthy aging, creating opportunities to partner with nutraceutical brands, clinics, and wellness platforms seeking targeted probiotic ingredients with clinical claims.

Global R&D Footprint With in-house R&D in the United States and Switzerland, the company can support international collaborations, cross-border product development, and regulatory alignment, making it attractive for global projects or licensing deals.

Strategic Leadership Growth The appointment of Steve Prescott as President in 2024 signals a growth-oriented trajectory and potential for strategic partnerships, licensing, or exclusive supply agreements as the company scales.

Early-Stage Growth Potential Operating with a small team and modest revenue, Bien-Etre Labs appears open to pilot programs, white-label manufacturing, and early-stage CDMO partnerships that allow brands to bring probiotic products to market quickly while building a proven track record.

IP Platform Value Boasting a novel platform for bioactive agents and a focus on healthy aging, the business presents opportunities to license or co-develop proprietary strains, delivery technologies, or clinical evidence packages with pharma- or nutraceutical-oriented customers seeking scientifically validated probiotics.